BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 436357)

  • 1. Single and divided doses of penbutolol.
    Müller FO; Hundt HK; Bromley PA; Torres J; Vanderbeke O
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):528-35. PubMed ID: 436357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man.
    Wellstein A; Palm D
    Eur J Clin Pharmacol; 1985; 29(3):293-300. PubMed ID: 3000796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
    Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
    Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic and pharmacokinetic study of oral and intravenous penbutolol.
    Vedin JA; Wilhelmsson C; Maass L; Peterson LE
    Eur J Clin Pharmacol; 1983; 25(4):529-34. PubMed ID: 6653649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
    Nami R; Martinelli M; Bianchini C; Gennari C
    Minerva Med; 1988 Nov; 79(11):965-71. PubMed ID: 3059235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.
    Silke B; Verma SP; Hussain M; Nelson GI; Okoli RC; Taylor SH
    Br J Clin Pharmacol; 1983 Nov; 16(5):529-35. PubMed ID: 6315039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidine.
    Spahn H; Kirch W; Hajdu P; Mutschler E; Ohnhaus EE
    Eur J Clin Pharmacol; 1986; 29(5):555-60. PubMed ID: 3956561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of penbutolol on glomerular filtration.
    Meyer BH; Müller FO; Lötter MG; Iturralde MP; Grigoleit HG
    S Afr Med J; 1981 Aug; 60(6):243-4. PubMed ID: 7020108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.
    Brockmeier D; Hajdù P; Henke W; Mutschler E; Palm D; Rupp W; Spahn H; Verho MT; Wellstein A
    Eur J Clin Pharmacol; 1988; 35(6):613-23. PubMed ID: 2906875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penbutolol in hypertension--single daily doses versus divided dosage schedule.
    Yajnik VH; Nandi JS; Karvadia SV
    J Assoc Physicians India; 1982 Feb; 30(2):85-8. PubMed ID: 6763031
    [No Abstract]   [Full Text] [Related]  

  • 12. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
    Kubik MM; Hanks GW
    Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma level profiles and clinical response of penbutolol after three different single oral doses in man.
    Jun HW; Hayes SL; Vallner JJ; Honigberg IL; Rojos AE; Stewart JT
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):415-23. PubMed ID: 489760
    [No Abstract]   [Full Text] [Related]  

  • 14. Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1981 Jul; 22(1):1-25. PubMed ID: 7261952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic sympathomimetic activity of penbutolol.
    Nyberg G; Wilhelmsson C; Vedin A
    Eur J Clin Pharmacol; 1979; 16(6):381-6. PubMed ID: 43255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of penbutolol and its metabolites in renal insufficiency.
    Bernard N; Cuisinaud G; Pozet N; Zech PY; Sassard J
    Eur J Clin Pharmacol; 1985; 29(2):215-9. PubMed ID: 4076321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penbutolol: a new beta-adrenergic blocking agent.
    Schlanz KD; Thomas RL
    DICP; 1990 Apr; 24(4):403-8. PubMed ID: 2183495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in penbutolol central response as a cause of changes in its serum protein binding.
    Martínez Jordá R; Aguirre C; Calvo R; Rodríguez-Sasiaín JM; Erill S
    J Pharm Pharmacol; 1990 Mar; 42(3):164-6. PubMed ID: 1974610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extent of beta-blocking action of S- and R-penbutolol during exercise testing (author's transl)].
    Kober G; Schulz W; Hermann HJ; Kaltenbach M
    Z Kardiol; 1982 Apr; 71(4):289-94. PubMed ID: 6283753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.